ADVFN Logo
Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers
Avicanna Inc

Avicanna Inc (AVCN)

0.34
0.00
(0.00%)
Closed July 24 4:12PM

Professional-Grade Tools, for Individual Investors.

Key stats and details

Current Price
0.34
Bid
0.325
Ask
0.34
Volume
100,271
0.33 Day's Range 0.36
0.20 52 Week Range 0.60
Market Cap
Previous Close
0.34
Open
0.35
Last Trade
500
@
0.34
Last Trade Time
Financial Volume
-
VWAP
-
Average Volume (3m)
165,318
Shares Outstanding
74,953,000
Dividend Yield
-
PE Ratio
-2.92
Earnings Per Share (EPS)
-0.12
Revenue
16.79M
Net Profit
-8.74M

About Avicanna Inc

Sector
Medicinal Chems,botanicl Pds
Industry
Medicinal Chems,botanicl Pds
Headquarters
Toronto, Ontario, Can
Founded
1970
Avicanna Inc is listed in the Medicinal Chems,botanicl Pds sector of the Toronto Stock Exchange with ticker AVCN. The last closing price for Avicanna was $0.34. Over the last year, Avicanna shares have traded in a share price range of $ 0.20 to $ 0.60.

Avicanna currently has 74,953,000 shares outstanding. The market capitalization of Avicanna is $25.48 million. Avicanna has a price to earnings ratio (PE ratio) of -2.92.

AVCN Latest News

Avicanna Subsidiary Completes Export of Aureus Branded CBG into Singapore

This marks the first export into Asia, the 18th international market for Aureus branded products and 21st market for all Avicanna products TORONTO, July 11, 2024 (GLOBE NEWSWIRE) -- Avicanna...

Avicanna Announces Results of Annual General Meeting & Provides Corporate Update

TORONTO, July 10, 2024 (GLOBE NEWSWIRE) -- Avicanna Inc. (“Avicanna” or the “Company”) (TSX: AVCN) (OTCQX: AVCNF) (FSE: 0NN) a biopharmaceutical company focused on the development...

Life Science Virtual Investor Forum Presentations Now Available for Online Viewing

NEW YORK, June 21, 2024 (GLOBE NEWSWIRE) -- Virtual Investor Conferences, the leading proprietary investor conference series, today announced the presentations from the Life Science Virtual...

Avicanna General Meeting

TORONTO, June 19, 2024 (GLOBE NEWSWIRE) -- Avicanna Inc. (“Avicanna” or the “Company) (TSX: AVCN) (OTCQX: AVCNF) (FSE: 0NN) a biopharmaceutical company focused on the development, manufacturing...

Avicanna Announces USPTO Issuance of Patent SEDDS Technology

TORONTO, June 19, 2024 (GLOBE NEWSWIRE) -- Avicanna Inc. (“Avicanna” or “Company”) (TSX: AVCN) (OTCQX: AVCNF) (FSE: 0NN), a biopharmaceutical company focused on the development, manufacturing...

Avicanna Reports Q1 2024 and First Positive Adjusted EBIDTA Quarter

Best Quarterly Results in Company’s History from a Financial Perspective.EBITDA Improvements Driven by Record Revenues, Record Margins and Operational Efficiencies.Marketing Authorization of...

Avicanna Announces Results of Study in Patients with Epidermolysis Bullosa

The study conducted at The Hospital for Sick Children evaluated wound healing, pain, and itch.55% of patients enrolled in Study reported improvements in wound healing, 45% displayed wound...

Avicanna Announces Closing of Non-brokered Private Placement

TORONTO, April 18, 2024 (GLOBE NEWSWIRE) -- Avicanna Inc. (“Avicanna” or the “Company”) (TSX: AVCN) (OTCQX: AVCNF) (FSE: 0NN) a biopharmaceutical company focused on the development...

Avicanna Announces Completion of Topical Gel Observational Real-World Evidence Study

TORONTO, April 10, 2024 (GLOBE NEWSWIRE) -- Avicanna Inc. (“Avicanna” or the “Company”) (TSX: AVCN) (OTCQX: AVCNF) (FSE: 0NN) a biopharmaceutical company focused on the development...

Avicanna Reports Full Year 2023 Audited Financial Results 

$16.8M in Revenue, representing an increase of 314% from 2022$6.7M Consolidated gross Profit, representing an increase of 500% from 2022 TORONTO, April 02, 2024 (GLOBE NEWSWIRE) -- Avicanna Inc...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-0.155-31.31313131310.4950.50.33866190.38282078CS
4-0.02-5.555555555560.360.550.331586760.41570667CS
12-0.02-5.555555555560.360.550.21653180.32265214CS
260.0257.936507936510.3150.60.21337040.37241476CS
520.03511.47540983610.3050.60.21531530.34352078CS
156-0.67-66.33663366341.011.010.16857250.36946827CS
260-5.86-94.51612903236.26.20.16762010.87494731CS

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
NUZENuZee Inc
$ 3.2954
(219.94%)
129.59M
DRMADermata Therapeutics Inc
$ 2.55
(96.15%)
62.37M
PIRSPieris Pharmaceuticals Inc
$ 14.9491
(87.33%)
5.51M
SLNASelina Hospitality PLC
$ 0.0456
(75.38%)
1.21B
QXOQXO Inc
$ 119.99
(51.31%)
216.09k
NXTTNext Technology Holding Inc
$ 2.50
(-57.04%)
965.73k
NUWENewellis Inc
$ 2.48
(-40.24%)
1.01M
LITMSnow Lake Resources Ltd
$ 0.625
(-35.43%)
5.76M
VWEVintage Wine Estates Inc
$ 0.0732
(-34.58%)
37.22M
CONNConns Inc
$ 0.345
(-31.95%)
4.45M
SLNASelina Hospitality PLC
$ 0.0456
(75.38%)
1.22B
NVDANVIDIA Corporation
$ 114.25
(-6.80%)
327.86M
SGMOSangamo Therapeutics Inc
$ 0.5584
(39.15%)
263.13M
SQQQProShares UltraPro Short QQQ
$ 9.06
(10.76%)
203.95M
TSLATesla Inc
$ 215.99
(-12.33%)
168.55M

Discussion

View Full Feed
ap17 ap17 2 minutes ago
LOL, he works there.
SHIBUSD
hap0206 hap0206 2 minutes ago
For me and you -- for sure -- we pay the $78 fillup with a debit card -- so many pay with a credit card -- paid with another credit card -- credit card dept up $500b under biden economics -- $9b four years under trump economic policies -- gas is cheap -- right you are
DTGoody DTGoody 3 minutes ago
For the short-term it sucks being on the Expert Market! I have faith in this investment 100% that we will do very well on the other side of this.
RSPI
Moonlazer Moonlazer 4 minutes ago
https://imgur.com/a/pPcw52K

Just a quick look at what I see.
SPY
DiscoverGold DiscoverGold 5 minutes ago
Cathie Wood & Ark Invest's Buys 33,143 Shares of Tesla Inc. (TSLA)
By: Ark Invest Daily | July 24, 2024

• Cathie Wood and Ark Invest's trade activity from today 7/24.

https://pbs.twimg.com/media/GTSv8x-WkAAiz93?format=jpg&name=large

https:/
TSLA
learningthetruth learningthetruth 6 minutes ago
Koolaid, same guy that said O/S went up by 3 Billion.....

🤡 he is. Of course he deleted those posts already as well!
SPZI
don estaban don estaban 6 minutes ago
We have had big Vol. The last week has to take off sooner then later
SXTC
mick mick 6 minutes ago
https://patriots4truth.org/2020/09/11/citizen-files-lawsuit-against-kamala-harris-for-illegal-status-as-vp-candidate/
N-13 N-13 7 minutes ago
Wow, bottom falling out here. May have to wait for next week for $72k again.
BTCUSD
badgerkid badgerkid 9 minutes ago
Surfkast, and where are the shares coming from if not the shorts? Who's actually selling shares? It's an interesting situation that we find ourselves in with the SI increasing while funds are increasing their positions as well. The dam may break soon and if it breaks we may see a flood of shorts
IOVA
Golden Cross Golden Cross 9 minutes ago
✈️✈️✈️
BLEG
janice shell janice shell 10 minutes ago
And now, Meta scientist Alma Bardon is suing Uzi Sasson and the company for wrongful dismissal...

https://www.allnovascotia.com/headlines?lineup=business&story_key=MTc4ODE0
MMAT
RammageRaul RammageRaul 10 minutes ago
Safest plays out there NNAX lets rock and roll
NNAX
don estaban don estaban 10 minutes ago
I picked up about 15k and they always filled me between bid and ask
MVNT
RMS555 RMS555 11 minutes ago
how is your favorite stock (BLLB) doing after pumping it for almost 10 years? LMAO!

Ill give you a hint; its at its 2 year low pretty much with not a word about this new merger.

It would be nice to know a little bit about this Green Mantis company and what their plans
BLLB
Moonlazer Moonlazer 11 minutes ago
If this doesn't bounce here, prepare for 530. At a long corridor trendline right now. Critical moment for the tech sector as a whole.
SPY
cowtown jay cowtown jay 11 minutes ago
I don't think Taran acquired all of the Humanigen patents. This bankruptcy case is going to be closed out, with all creditors paid, and our merged entity could continue to use what will be the well-capitalized shell, which we'll quickly relist on the OTC with our new ticker, until Nasdaq requiremen
dstock07734 dstock07734 12 minutes ago
Maybe yes for colorectal cancer which has a collaboration trial between Merck and NWBO.
NWBO
mick mick 12 minutes ago
WILD New Information Released About Trump Shooting
https://www.youtube.com/watch?v=vdIPyMPihz8&ab_channel=TalkingFedswithHarryLitman

https://youtu.be/vdIPyMPihz8
blackhawks blackhawks 12 minutes ago
Why would you call attention to his 'reading it from a teleprompter'? As IF any oval office speech has EVER been winged?

Seriously, man.
snax snax 12 minutes ago
Gotta dump before the pump
BTCUSD
Nytoncva Nytoncva 12 minutes ago
Does anyone with ridiculous price targets understand dilution? We are not going to 10.00 with the same 400M shares. If all goes excellent, a move near $1 will occur while OTC. Most likely a 1/10 RS to uplist to Nasdaq taking it $7-$10, then anyone’s guess from there, but company will need money,
RDGL
Gregg4 Gregg4 12 minutes ago
Unless they have all been converted
ESPR
Eli's Gone Eli's Gone 13 minutes ago
Uncle...
DJPele DJPele 13 minutes ago
_
NWBO